“Phase 3 Trial Demonstrates that MC2-01 Cream has Improved Treatment Efficacy Compared to Calcipotriene Plus Betamethasone Dipropionate Topical Suspension in Patients with Mild to Moderate Psoriasis Vulgaris”, J of Skin, vol. 4, no. 5, p. s36, Sep. 2020, doi: 10.25251/skin.4.supp.36.